デフォルト表紙
市場調査レポート
商品コード
1473623

経口メロキシカムの世界市場に関する洞察、2030年までの予測

Global Oral Meloxicam Market Insights, Forecast to 2030

出版日: | 発行: QYResearch | ページ情報: 英文 149 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
経口メロキシカムの世界市場に関する洞察、2030年までの予測
出版日: 2024年05月07日
発行: QYResearch
ページ情報: 英文 149 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、経口メロキシカム (Oral Meloxicam) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 経口メロキシカムの製品概要
  • 市場:タイプ別
    • 世界の経口メロキシカムの市場規模成長率:タイプ別, 2019 VS 2023 VS 2030
    • Tablets
    • Capsules
  • 市場:用途別
    • 世界の経口メロキシカムの市場規模成長率:用途別, 2019 VS 2023 VS 2030
    • Rheumatoid Arthritis
    • Osteoarthritis
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の経口メロキシカムの収益 推定および予測 2019-2030
  • 世界の経口メロキシカムの収益:地域別
    • 世界の経口メロキシカムの収益:地域別: 2019 VS 2023 VS 2030
    • 世界の経口メロキシカムの収益:地域別 (2019-2024)
    • 世界の経口メロキシカムの収益:地域別 (2025-2030)
    • 世界の経口メロキシカムの収益市場シェア 地域別 (2019-2030)
  • 世界の経口メロキシカム 売上予測・予想 2019-2030
  • 世界の経口メロキシカムの販売:地域別
    • 世界の経口メロキシカムの販売:地域別: 2019 VS 2023 VS 2030
    • 世界の経口メロキシカムの販売:地域別 (2019-2024)
    • 世界の経口メロキシカムの販売:地域別 (2025-2030)
    • 世界の経口メロキシカムの販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア(中国を除く)
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合:企業別

  • 世界の経口メロキシカムの販売:企業別
    • 世界の経口メロキシカムの販売:企業別 (2019-2024)
    • 世界の経口メロキシカムの販売市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 経口メロキシカム in 2023
  • 世界の経口メロキシカムの収益:企業別
    • 世界の経口メロキシカムの収益:企業別 (2019-2024)
    • 世界の経口メロキシカムの収益市場シェア:企業別 (2019-2024)
    • 世界の上位10・上位5企業: 経口メロキシカムの収益 2023
  • 世界の主要企業 経口メロキシカム, 業界ランキング, 2021 VS 2022
  • 世界の経口メロキシカムの販売価格:企業別 (2019-2024)
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の経口メロキシカムの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 経口メロキシカム, 製造拠点分布と本社
  • 世界の主要メーカー 経口メロキシカム, 提供製品と用途
  • 世界の主要メーカー 経口メロキシカム, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界の経口メロキシカムの販売:タイプ別
    • 世界の経口メロキシカムの販売実績:タイプ別 (2019-2024)
    • 世界の経口メロキシカムの販売予測:タイプ別 (2025-2030)
    • 世界の経口メロキシカムの販売市場シェア:タイプ別 (2019-2030)
  • 世界の経口メロキシカム 収益:タイプ別
    • 世界の経口メロキシカムの収益実績:タイプ別 (2019-2024)
    • 世界の経口メロキシカムの収益予測:タイプ別 (2025-2030)
    • 世界の経口メロキシカムの収益市場シェア:タイプ別 (2019-2030)
  • 世界の経口メロキシカムの価格:タイプ別
    • 世界の経口メロキシカムの価格:タイプ別 (2019-2024)
    • 世界の経口メロキシカムの価格予測:タイプ別 (2025-2030)

第5章 市場規模:用途別

  • 世界の経口メロキシカムの販売:用途別
    • 世界の経口メロキシカムの販売実績:用途別 (2019-2024)
    • 世界の経口メロキシカムの販売予測:用途別 (2025-2030)
    • 世界の経口メロキシカムの販売市場シェア:用途別 (2019-2030)
  • 世界の経口メロキシカムの収益:用途別
    • 世界の経口メロキシカムの収益実績:用途別 (2019-2024)
    • 世界の経口メロキシカムの収益予測:用途別 (2025-2030)
    • 世界の経口メロキシカムの収益市場シェア:用途別 (2019-2030)
  • 世界の経口メロキシカムの価格:用途別
    • 世界の経口メロキシカムの価格:用途別 (2019-2024)
    • 世界の経口メロキシカムの価格予測:用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ 経口メロキシカム 市場規模:タイプ別
    • 米国・カナダ 経口メロキシカムの販売:タイプ別 (2019-2030)
    • 米国・カナダ 経口メロキシカム 収益:タイプ別 (2019-2030)
  • 米国・カナダ 経口メロキシカム 市場規模:用途別
    • 米国・カナダ 経口メロキシカムの販売:用途別 (2019-2030)
    • 米国・カナダ 経口メロキシカムの収益:用途別 (2019-2030)
  • 米国・カナダ 経口メロキシカム 市場規模:国別
    • 米国・カナダ 経口メロキシカムの収益:国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 経口メロキシカムの収益:国別 (2019-2030)
    • 米国・カナダ 経口メロキシカムの販売:国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州の経口メロキシカム 市場規模:タイプ別
    • 欧州の経口メロキシカムの販売:タイプ別 (2019-2030)
    • 欧州の経口メロキシカム 収益:タイプ別 (2019-2030)
  • 欧州の経口メロキシカム 市場規模:用途別
    • 欧州の経口メロキシカムの販売:用途別 (2019-2030)
    • 欧州の経口メロキシカムの収益:用途別 (2019-2030)
  • 欧州の経口メロキシカム 市場規模:国別
    • 欧州の経口メロキシカムの収益:国別: 2019 VS 2023 VS 2030
    • 欧州の経口メロキシカムの収益:国別 (2019-2030)
    • 欧州の経口メロキシカムの販売:国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の経口メロキシカム 市場規模:タイプ別
    • 中国の経口メロキシカムの販売:タイプ別 (2019-2030)
    • 中国の経口メロキシカム 収益:タイプ別 (2019-2030)
  • 中国の経口メロキシカム 市場規模:用途別
    • 中国の経口メロキシカムの販売:用途別 (2019-2030)
    • 中国の経口メロキシカムの収益:用途別 (2019-2030)

第9章 アジア(中国を除く)

  • アジア地域 経口メロキシカム 市場規模:タイプ別
    • アジア地域 経口メロキシカムの販売:タイプ別 (2019-2030)
    • アジア地域 経口メロキシカム 収益:タイプ別 (2019-2030)
  • アジア地域 経口メロキシカム 市場規模:用途別
    • アジア地域 経口メロキシカムの販売:用途別 (2019-2030)
    • アジア地域 経口メロキシカムの収益:用途別 (2019-2030)
  • アジア地域 経口メロキシカム 市場規模:地域別
    • アジア地域 経口メロキシカムの収益:地域別: 2019 VS 2023 VS 2030
    • アジア地域 経口メロキシカムの収益:地域別 (2019-2030)
    • アジア地域 経口メロキシカムの販売:地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの経口メロキシカム 市場規模:タイプ別
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの販売:タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカム 収益:タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの経口メロキシカム 市場規模:用途別
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの販売:用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの収益:用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの経口メロキシカム 市場規模:国別
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの収益:国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの収益:国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの経口メロキシカムの販売:国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Boehringer Ingelheim
  • Mylan
  • Teva Pharmaceutical
  • Lupin
  • Apotex
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals
  • Qilu Pharmaceutical
  • Yangtze River Pharmaceutical
  • Zhejiang Xianju Pharmaceutical
  • Youcare Pharmaceutical

第12章 業界チェーンと販売チャネルの分析

  • 経口メロキシカム 業界チェーン分析
  • 経口メロキシカム 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 経口メロキシカム 生産形態とプロセス
  • 経口メロキシカム 販売およびマーケティング
    • 経口メロキシカム 販売チャネルs
    • 経口メロキシカム 卸業者
  • 経口メロキシカム 顧客

第13章 経口メロキシカム 市場動向

  • 経口メロキシカム 業界動向
  • 経口メロキシカム 市場の促進要因
  • 経口メロキシカム 市場の課題
  • 経口メロキシカム 市場の抑制要因

第14章 主な調査結果 世界の経口メロキシカムの主な市場調査結果

第15章 付録

図表

List of Tables

Table 1. Global Oral Meloxicam Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Tablets

Table 3. Major Manufacturers of Capsules

Table 4. Global Oral Meloxicam Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Oral Meloxicam Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Oral Meloxicam Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Oral Meloxicam Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Oral Meloxicam Revenue Market Share by Region (2019-2024)

Table 9. Global Oral Meloxicam Revenue Market Share by Region (2025-2030)

Table 10. Global Oral Meloxicam Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Oral Meloxicam Sales by Region (2019-2024) & (K Units)

Table 12. Global Oral Meloxicam Sales by Region (2025-2030) & (K Units)

Table 13. Global Oral Meloxicam Sales Market Share by Region (2019-2024)

Table 14. Global Oral Meloxicam Sales Market Share by Region (2025-2030)

Table 15. Global Oral Meloxicam Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Oral Meloxicam Sales Share by Manufacturers (2019-2024)

Table 17. Global Oral Meloxicam Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Oral Meloxicam Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Oral Meloxicam, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Oral Meloxicam Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Oral Meloxicam Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Oral Meloxicam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Meloxicam as of 2023)

Table 23. Global Key Manufacturers of Oral Meloxicam, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Oral Meloxicam, Product Offered and Application

Table 25. Global Key Manufacturers of Oral Meloxicam, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 28. Global Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 29. Global Oral Meloxicam Sales Share by Type (2019-2024)

Table 30. Global Oral Meloxicam Sales Share by Type (2025-2030)

Table 31. Global Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Oral Meloxicam Revenue Share by Type (2019-2024)

Table 34. Global Oral Meloxicam Revenue Share by Type (2025-2030)

Table 35. Oral Meloxicam Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Oral Meloxicam Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 38. Global Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 39. Global Oral Meloxicam Sales Share by Application (2019-2024)

Table 40. Global Oral Meloxicam Sales Share by Application (2025-2030)

Table 41. Global Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Oral Meloxicam Revenue Share by Application (2019-2024)

Table 44. Global Oral Meloxicam Revenue Share by Application (2025-2030)

Table 45. Oral Meloxicam Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Oral Meloxicam Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Oral Meloxicam Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Oral Meloxicam Sales by Country (2025-2030) & (K Units)

Table 60. Europe Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 61. Europe Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 62. Europe Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 65. Europe Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 66. Europe Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Oral Meloxicam Sales by Country (2019-2024) & (K Units)

Table 72. Europe Oral Meloxicam Sales by Country (2025-2030) & (K Units)

Table 73. China Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 74. China Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 75. China Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 78. China Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 79. China Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 82. Asia Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 83. Asia Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 86. Asia Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 87. Asia Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Oral Meloxicam Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Oral Meloxicam Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Oral Meloxicam Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Oral Meloxicam Sales by Region (2019-2024) & (K Units)

Table 93. Asia Oral Meloxicam Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Oral Meloxicam Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Oral Meloxicam Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Oral Meloxicam Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Oral Meloxicam Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Oral Meloxicam Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Oral Meloxicam Sales by Country (2025-2030) & (K Units)

Table 107. Boehringer Ingelheim Company Information

Table 108. Boehringer Ingelheim Description and Major Businesses

Table 109. Boehringer Ingelheim Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Boehringer Ingelheim Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Boehringer Ingelheim Recent Developments

Table 112. Mylan Company Information

Table 113. Mylan Description and Major Businesses

Table 114. Mylan Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Mylan Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Mylan Recent Developments

Table 117. Teva Pharmaceutical Company Information

Table 118. Teva Pharmaceutical Description and Major Businesses

Table 119. Teva Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Teva Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Teva Pharmaceutical Recent Developments

Table 122. Lupin Company Information

Table 123. Lupin Description and Major Businesses

Table 124. Lupin Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Lupin Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Lupin Recent Developments

Table 127. Apotex Company Information

Table 128. Apotex Description and Major Businesses

Table 129. Apotex Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Apotex Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Apotex Recent Developments

Table 132. Dr. Reddy's Laboratories Company Information

Table 133. Dr. Reddy's Laboratories Description and Major Businesses

Table 134. Dr. Reddy's Laboratories Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Dr. Reddy's Laboratories Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Dr. Reddy's Laboratories Recent Developments

Table 137. Glenmark Pharmaceuticals Company Information

Table 138. Glenmark Pharmaceuticals Description and Major Businesses

Table 139. Glenmark Pharmaceuticals Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Glenmark Pharmaceuticals Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Glenmark Pharmaceuticals Recent Developments

Table 142. Qilu Pharmaceutical Company Information

Table 143. Qilu Pharmaceutical Description and Major Businesses

Table 144. Qilu Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Qilu Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Qilu Pharmaceutical Recent Developments

Table 147. Yangtze River Pharmaceutical Company Information

Table 148. Yangtze River Pharmaceutical Description and Major Businesses

Table 149. Yangtze River Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. Yangtze River Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Yangtze River Pharmaceutical Recent Developments

Table 152. Zhejiang Xianju Pharmaceutical Company Information

Table 153. Zhejiang Xianju Pharmaceutical Description and Major Businesses

Table 154. Zhejiang Xianju Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Zhejiang Xianju Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Zhejiang Xianju Pharmaceutical Recent Developments

Table 157. Youcare Pharmaceutical Company Information

Table 158. Youcare Pharmaceutical Description and Major Businesses

Table 159. Youcare Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Youcare Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Youcare Pharmaceutical Recent Developments

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Oral Meloxicam Distributors List

Table 165. Oral Meloxicam Customers List

Table 166. Oral Meloxicam Market Trends

Table 167. Oral Meloxicam Market Drivers

Table 168. Oral Meloxicam Market Challenges

Table 169. Oral Meloxicam Market Restraints

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Meloxicam Product Picture

Figure 2. Global Oral Meloxicam Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Meloxicam Market Share by Type: 2023 & 2030

Figure 4. Tablets Product Picture

Figure 5. Capsules Product Picture

Figure 6. Global Oral Meloxicam Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Oral Meloxicam Market Share by Application: 2023 & 2030

Figure 8. Rheumatoid Arthritis

Figure 9. Osteoarthritis

Figure 10. Oral Meloxicam Report Years Considered

Figure 11. Global Oral Meloxicam Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 13. Global Oral Meloxicam Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 14. Global Oral Meloxicam Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Oral Meloxicam Revenue Market Share by Region (2019-2030)

Figure 16. Global Oral Meloxicam Sales (2019-2030) & (K Units)

Figure 17. Global Oral Meloxicam Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 18. Global Oral Meloxicam Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Oral Meloxicam Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Oral Meloxicam Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Oral Meloxicam Sales YoY (2019-2030) & (K Units)

Figure 24. China Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Oral Meloxicam Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Oral Meloxicam Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Global Oral Meloxicam Sales Share by Manufacturers (2023)

Figure 30. The Oral Meloxicam Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. Global Oral Meloxicam Revenue Share by Manufacturers (2023)

Figure 32. The Top 5 and 10 Largest Manufacturers of Oral Meloxicam in the World: Market Share by Oral Meloxicam Revenue in 2023

Figure 33. Global Oral Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 35. Global Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 36. Global Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 37. Global Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Oral Meloxicam Revenue Share by Country (2019-2030)

Figure 43. US & Canada Oral Meloxicam Sales Share by Country (2019-2030)

Figure 44. US Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 47. Europe Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 48. Europe Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 49. Europe Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 50. Europe Oral Meloxicam Revenue Share by Country (2019-2030)

Figure 51. Europe Oral Meloxicam Sales Share by Country (2019-2030)

Figure 52. Germany Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 53. France Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 57. China Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 58. China Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 59. China Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 60. China Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 61. Asia Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 62. Asia Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 63. Asia Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 64. Asia Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 65. Asia Oral Meloxicam Revenue Share by Region (2019-2030)

Figure 66. Asia Oral Meloxicam Sales Share by Region (2019-2030)

Figure 67. Japan Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 71. India Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 72. Australia Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 73. Middle East, Africa and Latin America Oral Meloxicam Sales Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Oral Meloxicam Revenue Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Oral Meloxicam Sales Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Oral Meloxicam Revenue Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Oral Meloxicam Revenue Share by Country (2019-2030)

Figure 78. Middle East, Africa and Latin America Oral Meloxicam Sales Share by Country (2019-2030)

Figure 79. Brazil Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 80. Mexico Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 81. Turkey Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 82. Israel Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 83. GCC Countries Oral Meloxicam Revenue (2019-2030) & (US$ Million)

Figure 84. Oral Meloxicam Value Chain

Figure 85. Oral Meloxicam Production Process

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

目次

This research report focuses on the Oral Meloxicam Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Oral Meloxicam Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Oral Meloxicam Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Tablets
    • 1.2.3 Capsules
  • 1.3 Market by Application
    • 1.3.1 Global Oral Meloxicam Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Rheumatoid Arthritis
    • 1.3.3 Osteoarthritis
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Oral Meloxicam Revenue Estimates and Forecasts 2019-2030
  • 2.2 Global Oral Meloxicam Revenue by Region
    • 2.2.1 Global Oral Meloxicam Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Oral Meloxicam Revenue by Region (2019-2024)
    • 2.2.3 Global Oral Meloxicam Revenue by Region (2025-2030)
    • 2.2.4 Global Oral Meloxicam Revenue Market Share by Region (2019-2030)
  • 2.3 Global Oral Meloxicam Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Oral Meloxicam Sales by Region
    • 2.4.1 Global Oral Meloxicam Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Oral Meloxicam Sales by Region (2019-2024)
    • 2.4.3 Global Oral Meloxicam Sales by Region (2025-2030)
    • 2.4.4 Global Oral Meloxicam Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

  • 3.1 Global Oral Meloxicam Sales by Manufacturers
    • 3.1.1 Global Oral Meloxicam Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Oral Meloxicam Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Meloxicam in 2023
  • 3.2 Global Oral Meloxicam Revenue by Manufacturers
    • 3.2.1 Global Oral Meloxicam Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Oral Meloxicam Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Oral Meloxicam Revenue in 2023
  • 3.3 Global Key Players of Oral Meloxicam, Industry Ranking, 2021 VS 2022
  • 3.4 Global Oral Meloxicam Sales Price by Manufacturers (2019-2024)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Oral Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Oral Meloxicam, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Oral Meloxicam, Product Offered and Application
  • 3.8 Global Key Manufacturers of Oral Meloxicam, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Oral Meloxicam Sales by Type
    • 4.1.1 Global Oral Meloxicam Historical Sales by Type (2019-2024)
    • 4.1.2 Global Oral Meloxicam Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Oral Meloxicam Sales Market Share by Type (2019-2030)
  • 4.2 Global Oral Meloxicam Revenue by Type
    • 4.2.1 Global Oral Meloxicam Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Oral Meloxicam Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Oral Meloxicam Revenue Market Share by Type (2019-2030)
  • 4.3 Global Oral Meloxicam Price by Type
    • 4.3.1 Global Oral Meloxicam Price by Type (2019-2024)
    • 4.3.2 Global Oral Meloxicam Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Oral Meloxicam Sales by Application
    • 5.1.1 Global Oral Meloxicam Historical Sales by Application (2019-2024)
    • 5.1.2 Global Oral Meloxicam Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Oral Meloxicam Sales Market Share by Application (2019-2030)
  • 5.2 Global Oral Meloxicam Revenue by Application
    • 5.2.1 Global Oral Meloxicam Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Oral Meloxicam Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Oral Meloxicam Revenue Market Share by Application (2019-2030)
  • 5.3 Global Oral Meloxicam Price by Application
    • 5.3.1 Global Oral Meloxicam Price by Application (2019-2024)
    • 5.3.2 Global Oral Meloxicam Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Oral Meloxicam Market Size by Type
    • 6.1.1 US & Canada Oral Meloxicam Sales by Type (2019-2030)
    • 6.1.2 US & Canada Oral Meloxicam Revenue by Type (2019-2030)
  • 6.2 US & Canada Oral Meloxicam Market Size by Application
    • 6.2.1 US & Canada Oral Meloxicam Sales by Application (2019-2030)
    • 6.2.2 US & Canada Oral Meloxicam Revenue by Application (2019-2030)
  • 6.3 US & Canada Oral Meloxicam Market Size by Country
    • 6.3.1 US & Canada Oral Meloxicam Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Oral Meloxicam Revenue by Country (2019-2030)
    • 6.3.3 US & Canada Oral Meloxicam Sales by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Oral Meloxicam Market Size by Type
    • 7.1.1 Europe Oral Meloxicam Sales by Type (2019-2030)
    • 7.1.2 Europe Oral Meloxicam Revenue by Type (2019-2030)
  • 7.2 Europe Oral Meloxicam Market Size by Application
    • 7.2.1 Europe Oral Meloxicam Sales by Application (2019-2030)
    • 7.2.2 Europe Oral Meloxicam Revenue by Application (2019-2030)
  • 7.3 Europe Oral Meloxicam Market Size by Country
    • 7.3.1 Europe Oral Meloxicam Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Oral Meloxicam Revenue by Country (2019-2030)
    • 7.3.3 Europe Oral Meloxicam Sales by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Oral Meloxicam Market Size by Type
    • 8.1.1 China Oral Meloxicam Sales by Type (2019-2030)
    • 8.1.2 China Oral Meloxicam Revenue by Type (2019-2030)
  • 8.2 China Oral Meloxicam Market Size by Application
    • 8.2.1 China Oral Meloxicam Sales by Application (2019-2030)
    • 8.2.2 China Oral Meloxicam Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Oral Meloxicam Market Size by Type
    • 9.1.1 Asia Oral Meloxicam Sales by Type (2019-2030)
    • 9.1.2 Asia Oral Meloxicam Revenue by Type (2019-2030)
  • 9.2 Asia Oral Meloxicam Market Size by Application
    • 9.2.1 Asia Oral Meloxicam Sales by Application (2019-2030)
    • 9.2.2 Asia Oral Meloxicam Revenue by Application (2019-2030)
  • 9.3 Asia Oral Meloxicam Market Size by Region
    • 9.3.1 Asia Oral Meloxicam Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Oral Meloxicam Revenue by Region (2019-2030)
    • 9.3.3 Asia Oral Meloxicam Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India
    • 9.3.9 Australia

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Oral Meloxicam Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Oral Meloxicam Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Oral Meloxicam Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Oral Meloxicam Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Oral Meloxicam Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Oral Meloxicam Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Oral Meloxicam Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Oral Meloxicam Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Oral Meloxicam Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Oral Meloxicam Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Corporate Profile

  • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Company Information
    • 11.1.2 Boehringer Ingelheim Overview
    • 11.1.3 Boehringer Ingelheim Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Boehringer Ingelheim Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Boehringer Ingelheim Recent Developments
  • 11.2 Mylan
    • 11.2.1 Mylan Company Information
    • 11.2.2 Mylan Overview
    • 11.2.3 Mylan Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Mylan Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Mylan Recent Developments
  • 11.3 Teva Pharmaceutical
    • 11.3.1 Teva Pharmaceutical Company Information
    • 11.3.2 Teva Pharmaceutical Overview
    • 11.3.3 Teva Pharmaceutical Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Teva Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Teva Pharmaceutical Recent Developments
  • 11.4 Lupin
    • 11.4.1 Lupin Company Information
    • 11.4.2 Lupin Overview
    • 11.4.3 Lupin Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 Lupin Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Lupin Recent Developments
  • 11.5 Apotex
    • 11.5.1 Apotex Company Information
    • 11.5.2 Apotex Overview
    • 11.5.3 Apotex Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Apotex Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Apotex Recent Developments
  • 11.6 Dr. Reddy's Laboratories
    • 11.6.1 Dr. Reddy's Laboratories Company Information
    • 11.6.2 Dr. Reddy's Laboratories Overview
    • 11.6.3 Dr. Reddy's Laboratories Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 Dr. Reddy's Laboratories Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Dr. Reddy's Laboratories Recent Developments
  • 11.7 Glenmark Pharmaceuticals
    • 11.7.1 Glenmark Pharmaceuticals Company Information
    • 11.7.2 Glenmark Pharmaceuticals Overview
    • 11.7.3 Glenmark Pharmaceuticals Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 Glenmark Pharmaceuticals Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Glenmark Pharmaceuticals Recent Developments
  • 11.8 Qilu Pharmaceutical
    • 11.8.1 Qilu Pharmaceutical Company Information
    • 11.8.2 Qilu Pharmaceutical Overview
    • 11.8.3 Qilu Pharmaceutical Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 Qilu Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Qilu Pharmaceutical Recent Developments
  • 11.9 Yangtze River Pharmaceutical
    • 11.9.1 Yangtze River Pharmaceutical Company Information
    • 11.9.2 Yangtze River Pharmaceutical Overview
    • 11.9.3 Yangtze River Pharmaceutical Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 Yangtze River Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Yangtze River Pharmaceutical Recent Developments
  • 11.10 Zhejiang Xianju Pharmaceutical
    • 11.10.1 Zhejiang Xianju Pharmaceutical Company Information
    • 11.10.2 Zhejiang Xianju Pharmaceutical Overview
    • 11.10.3 Zhejiang Xianju Pharmaceutical Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.10.4 Zhejiang Xianju Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Zhejiang Xianju Pharmaceutical Recent Developments
  • 11.11 Youcare Pharmaceutical
    • 11.11.1 Youcare Pharmaceutical Company Information
    • 11.11.2 Youcare Pharmaceutical Overview
    • 11.11.3 Youcare Pharmaceutical Oral Meloxicam Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.11.4 Youcare Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Youcare Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Oral Meloxicam Industry Chain Analysis
  • 12.2 Oral Meloxicam Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Oral Meloxicam Production Mode & Process
  • 12.4 Oral Meloxicam Sales and Marketing
    • 12.4.1 Oral Meloxicam Sales Channels
    • 12.4.2 Oral Meloxicam Distributors
  • 12.5 Oral Meloxicam Customers

13 Oral Meloxicam Market Dynamics

  • 13.1 Oral Meloxicam Industry Trends
  • 13.2 Oral Meloxicam Market Drivers
  • 13.3 Oral Meloxicam Market Challenges
  • 13.4 Oral Meloxicam Market Restraints

14 Key Findings in the Global Oral Meloxicam Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer